49 related articles for article (PubMed ID: 20497915)
21. Editorial: Targeted therapy for HER-2: personalized medicine for her, too.
Melichar B; Plebani M
Clin Chem Lab Med; 2012 Jan; 50(1):1-4. PubMed ID: 22505535
[No Abstract] [Full Text] [Related]
22. Precise predictive and therapeutic strategy for breast cancer.
Kyrochristos ID; Peristeri DV; Ziogas DE; Lykoudis EG; Roukos DH
Future Oncol; 2018 Aug; 14(18):1777-1780. PubMed ID: 29846090
[No Abstract] [Full Text] [Related]
23. The breast cancer market.
Syed BA
Nat Rev Drug Discov; 2015 Apr; 14(4):233-4. PubMed ID: 25829273
[No Abstract] [Full Text] [Related]
24. Molecular fingerprinting catches responders to therapeutic agents.
Malik S; Tan P; Ng PC
Genome Biol; 2013; 14(10):135. PubMed ID: 24176101
[TBL] [Abstract][Full Text] [Related]
25. Where to with HER2?
Sledge GW
Clin Breast Cancer; 2010 Feb; 10(1):18. PubMed ID: 20133253
[No Abstract] [Full Text] [Related]
26. HER2011: the changing face of HER2-positive breast cancer.
Sledge GW
Clin Breast Cancer; 2011 Mar; 11(1):9. PubMed ID: 21421515
[No Abstract] [Full Text] [Related]
27. TEACH: Tykerb evaluation after chemotherapy.
Moy B; Goss PE
Clin Breast Cancer; 2007 Feb; 7(6):489-92. PubMed ID: 17386127
[No Abstract] [Full Text] [Related]
28. Targeted therapy for human epidermal growth factor receptor 2-positive breast cancer: can there be too many active drugs?
Chandarlapaty S; Modi S
J Clin Oncol; 2011 Aug; 29(23):3111-3. PubMed ID: 21730267
[No Abstract] [Full Text] [Related]
29. Ten remarkable years.
Sledge GW
Clin Breast Cancer; 2010 Jun; 10(3):178. PubMed ID: 20497915
[No Abstract] [Full Text] [Related]
30. [Advances in research on treatment of breast cancer with lapatinib].
Ma CD; Shen KW; Shen ZZ
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):321-4. PubMed ID: 18953827
[No Abstract] [Full Text] [Related]
31. [Sensitivity of chemotherapy depending on hormone status in breast cancer].
Ito Y
Nihon Rinsho; 2007 Jun; 65 Suppl 6():568-71. PubMed ID: 17679212
[No Abstract] [Full Text] [Related]
32. [Neoadjuvant endocrine therapy for postmenopausal estrogen receptor-positive patients with breast cancer].
Zhang B
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):241-4. PubMed ID: 21575491
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
